0 Commentarii
0 Distribuiri
1K Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
-
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
U.S. Generic Drugs Market to Hit $131.8 Billion by 2033 GrowthU.S. Generic Drugs Market Poised for Steady Expansion Through 2033 The United States generic drugs market is witnessing consistent and strategic growth, supported by evolving healthcare demands, rising cost pressures, and an increasing focus on affordability. According to recent market insights from Renub Research, the industry is expected to expand from US$ 95.87 billion in 2024 to US$ 131.80...0 Commentarii 0 Distribuiri 954 Views 0 previzualizare
-
Antihypertensive Drugs Market Expanding with Rising Hypertension PrevalenceAccording to a new report from Intel Market Research, the global Antihypertensive Drugs market was valued at USD 31.96 billion in 2024 and is projected to grow from USD 33.12 billion in 2025 to reach USD 40.62 billion by 2034, exhibiting a CAGR of 3.6% during the forecast period (2025–2034). This steady growth trajectory is underpinned by the escalating global burden of hypertension,...0 Commentarii 0 Distribuiri 638 Views 0 previzualizare
-
Dobutamine Market Growing at 5.8% CAGR Through 2034According to a new report from Intel Market Research, the global Dobutamine market was valued at USD 1.05 billion in 2025 and is projected to grow from USD 1.12 billion in 2026 to USD 1.75 billion by 2034, exhibiting a robust CAGR of 5.8% during the forecast period (2026–2034). This growth is propelled by the rising global prevalence of cardiovascular diseases, the expanding aging...0 Commentarii 0 Distribuiri 632 Views 0 previzualizare
-
Global Cefalexin API Market to Reach USD 871 Million by 2034According to a new report from Intel Market Research, the global Cefalexin API market was valued at USD 571 million in 2024 and is projected to reach USD 871 million by 2034, growing at a robust CAGR of 6.4% during the forecast period (2025–2034). This growth is propelled by the increasing prevalence of bacterial infections, rising demand for generic antibiotics, and expanding...0 Commentarii 0 Distribuiri 354 Views 0 previzualizare
-
Global Cefalexin API Market to Reach USD 871 Million by 2034According to a new report from Intel Market Research, the global Cefalexin API market was valued at USD 571 million in 2024 and is projected to reach USD 871 million by 2034, growing at a robust CAGR of 6.4% during the forecast period (2025–2034). This growth is propelled by the increasing prevalence of bacterial infections, rising demand for generic antibiotics, and expanding...0 Commentarii 0 Distribuiri 315 Views 0 previzualizare
-
Global Ibuprofen Market Growing at 2.9% CAGR Through 2032According to a new report from Intel Market Research, the global ibuprofen market was valued at USD 87.4 million in 2024 and is projected to grow from USD 89.9 million in 2025 to USD 106 million by 2032, exhibiting a steady CAGR of 2.9% during the forecast period (2025–2032). This growth is driven by the increasing global burden of chronic pain conditions and inflammatory diseases, rapid...0 Commentarii 0 Distribuiri 7 Views 0 previzualizare
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek